tiprankstipranks
Trending News
More News >
Oxford Nanopore Technologies PLC (GB:ONT)
LSE:ONT

Oxford Nanopore Technologies PLC (ONT) AI Stock Analysis

Compare
110 Followers

Top Page

GB

Oxford Nanopore Technologies PLC

(LSE:ONT)

56Neutral
Oxford Nanopore Technologies PLC's overall stock score reflects a blend of steady revenue growth and strategic market initiatives, alongside ongoing challenges in profitability and cash flow management. Strong guidance and positive corporate events support the outlook, while technical indicators and valuation remain areas of concern.
Positive Factors
Analyst Rating
The stock is rated as Overweight, indicating a positive outlook by the analyst.
Financial Position
The company has zero debt and substantial cash and liquid investments of $472 million.
Investment and Funding
The company's balance sheet has been strengthened with fresh equity raised from Biomerieux and Novo Holdings.
Negative Factors
Competition and Market Environment
There is a deteriorating funding environment and increasing competition, adding uncertainty to the investment case.
Financial Challenges
There is an uncertain path to profitability, indicating potential financial challenges ahead.
Growth Guidance
The company has been downgraded to a Sell rating due to increasing downside risks to its mid-term growth guidance.

Oxford Nanopore Technologies PLC (ONT) vs. S&P 500 (SPY)

Oxford Nanopore Technologies PLC Business Overview & Revenue Model

Company DescriptionOxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
How the Company Makes MoneyOxford Nanopore Technologies makes money primarily through the sale of its sequencing devices and consumables required for sequencing. These include portable devices like the MinION, as well as larger systems such as the PromethION, which cater to different scale needs of genomic analysis. The company also generates revenue from software and data services that support sequencing operations. Additionally, ONT benefits from strategic partnerships and collaborations with research institutions, healthcare providers, and industry players, which can involve co-development agreements or licensing deals. This diversified revenue model allows ONT to capitalize on the growing demand for genomic sequencing technologies across multiple sectors.

Oxford Nanopore Technologies PLC Financial Statement Overview

Summary
Oxford Nanopore Technologies PLC exhibits revenue growth and a strong equity base, essential for long-term sustainability. However, persistent losses and negative cash flows underscore profitability and cash management challenges requiring strategic attention.
Income Statement
55
Neutral
Oxford Nanopore Technologies PLC shows a consistent revenue growth trend, with a 7.95% increase from 2023 to 2024. However, the company remains unprofitable, reflected by negative EBIT and net income margins, indicating ongoing challenges in cost management and profitability.
Balance Sheet
60
Neutral
The company maintains a solid equity base with an equity ratio of 79.03% in 2024, suggesting financial stability. However, the high debt-to-equity ratio of 0.08 indicates potential leverage concerns, although manageable due to strong equity.
Cash Flow
50
Neutral
Operating cash flow remains negative, highlighting cash management challenges. Despite an improvement in free cash flow to net income ratio, free cash flow remains negative, suggesting ongoing cash flow constraints that may impact future growth initiatives.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
183.19M169.67M198.60M133.66M113.86M
Gross Profit
105.39M90.48M123.81M73.19M46.88M
EBIT
-152.33M-168.61M-98.48M-164.53M-73.06M
EBITDA
-93.09M-105.71M-49.67M-140.34M-55.07M
Net Income Common Stockholders
-146.19M-154.51M-91.03M-167.61M-61.24M
Balance SheetCash, Cash Equivalents and Short-Term Investments
338.37M270.05M476.19M618.47M80.86M
Total Assets
742.05M777.06M823.89M841.87M281.21M
Total Debt
45.96M41.66M34.10M24.80M23.63M
Net Debt
-153.55M-178.88M-322.68M-463.04M-57.23M
Total Liabilities
155.71M133.21M130.33M137.89M95.28M
Stockholders Equity
586.34M643.85M693.56M703.98M185.93M
Cash FlowFree Cash Flow
-123.83M-164.59M-91.62M-84.64M-90.28M
Operating Cash Flow
-109.89M-137.30M-49.39M-53.83M-63.81M
Investing Cash Flow
15.03M-61.79M-65.79M-161.99M-26.94M
Financing Cash Flow
73.58M64.73M-13.71M622.90M158.58M

Oxford Nanopore Technologies PLC Technical Analysis

Technical Analysis Sentiment
Negative
Last Price120.60
Price Trends
50DMA
113.33
Positive
100DMA
122.12
Negative
200DMA
131.26
Negative
Market Momentum
MACD
3.55
Positive
RSI
48.56
Neutral
STOCH
33.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ONT, the sentiment is Negative. The current price of 120.6 is below the 20-day moving average (MA) of 123.85, above the 50-day MA of 113.33, and below the 200-day MA of 131.26, indicating a neutral trend. The MACD of 3.55 indicates Positive momentum. The RSI at 48.56 is Neutral, neither overbought nor oversold. The STOCH value of 33.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ONT.

Oxford Nanopore Technologies PLC Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
£307.44M7.8211.74%―38.80%―
GBONT
56
Neutral
£1.16B―-23.77%―7.97%12.94%
52
Neutral
$5.19B3.04-44.64%2.82%16.45%-0.53%
46
Neutral
£95.90M―167.16%―-100.00%-23.91%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ONT
Oxford Nanopore Technologies PLC
124.40
15.60
14.34%
GB:AVCT
Avacta Group plc
32.00
-9.00
-21.95%
GB:PRTC
PureTech Health
129.40
-97.10
-42.87%
GB:SCLP
Scancell Holdings
9.25
-0.85
-8.42%
OXBDF
Oxford BioMedica
4.07
-0.27
-6.22%
GB:4BB
4basebio UK Societas
1,125.00
-280.00
-19.93%

Oxford Nanopore Technologies PLC Earnings Call Summary

Earnings Call Date:Mar 04, 2025
(Q4-2024)
|
% Change Since: 14.75%|
Next Earnings Date:Sep 02, 2025
Earnings Call Sentiment Neutral
Oxford Nanopore reported strong revenue growth and cash positions, driven by increased demand for PromethION and new product launches. However, the company faces significant challenges due to U.S. federal funding uncertainties and currency headwinds, which could impact future growth. Despite these challenges, the company remains confident in its strategic positioning and opportunities in applied markets.
Q4-2024 Updates
Positive Updates
Strong Revenue Growth
Oxford Nanopore reported FY 2024 revenues at GBP 183.2 million, representing an 11.1% increase at constant currency and 23.3% on an underlying constant currency basis, in line with their guidance of 20% to 30% growth.
PromethION Flow Cell Utilization Increase
PromethION flow cell utilization increased by 36% from the first half to the second half of 2024, indicating higher demand for the company's sequencing technology.
Strong Cash Position
The company ended 2024 with a strong balance sheet, holding GBP 403.8 million in cash, supported by an GBP 80 million raise from new and existing investors in the second half.
Significant Advances in Applied Markets
The applied industrial segment grew over 40%, with significant contracts in plasmid sequencing and synthetic biology markets, displacing traditional methods like Sanger sequencing.
Innovative Product Launches
GridION Q-Line launched in 2024, with plans to roll out PromethION Q-Line in 2025, coupled with the ElysION platform for regulated workflows.
Negative Updates
Challenges with U.S. Federal Funding and Export Control Restrictions
The company faces headwinds due to U.S. federal funding uncertainties and export control restrictions, particularly affecting NIH funding, with significant impacts expected on future revenue.
Weakness in MinION Revenues
MinION revenues declined by nearly 10% due to the removal of the Mk1C device, affecting the overall growth in consumables.
Currency Headwinds
Currency fluctuations represented a GBP 5.3 million headwind, impacting reported growth figures.
Operational Challenges
The company acknowledged operational challenges and opportunities for improvement as it matures its processes and business operations.
Company Guidance
In the call, Oxford Nanopore provided comprehensive guidance for 2025, projecting revenue growth of 20% to 23% on a constant currency basis, driven by strong demand for their technology despite potential challenges like U.S. federal funding uncertainties and export control restrictions. They anticipate a gross margin of approximately 59%, representing a year-on-year increase of 100 basis points. The company expects overall growth in adjusted costs to be at the low end of their medium OpEx guidance. Medium-term goals include maintaining a compound annual growth rate of over 30%, targeting a gross margin greater than 62%, and achieving adjusted EBITDA breakeven by 2027 and cash flow positivity by 2028. Oxford Nanopore is focusing on expanding into applied industrial, biopharma, and clinical markets, with biopharma projected to constitute 20% to 30% of revenues by 2027. The company's recent pricing model changes could enhance revenue and margins, with potential mid-single-digit revenue growth and 50 to 100 basis points margin improvement over the medium term.

Oxford Nanopore Technologies PLC Corporate Events

Executive/Board ChangesRegulatory Filings and Compliance
Oxford Nanopore Awards Shares to CFO Under Incentive Plan
Neutral
May 14, 2025

Oxford Nanopore Technologies plc has announced a transaction involving the Share Incentive Plan (SIP), where 112 ordinary shares were awarded to Nick Keher, the Chief Financial Officer, as part of a purchase using his gross salary. The company also issued 112 matching shares to the SIP Trustee to satisfy the award under the SIP. This move is part of the company’s compliance with the UK Market Abuse Regulation, reflecting its commitment to transparent managerial practices and aligning employee incentives with company performance.

The most recent analyst rating on (GB:ONT) stock is a Buy with a £260.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC presents a mixed outlook. Strong revenue growth and strategic market positioning are promising, but ongoing unprofitability and cash flow challenges weigh heavily. Positive earnings call sentiment and corporate events offer some optimism, although valuation remains a concern due to the negative P/E ratio. Overall, the stock shows potential but requires attention to financial performance and profitability improvements.

To see Spark’s full report on GB:ONT stock, click here.

Delistings and Listing ChangesPrivate Placements and Financing
Oxford Nanopore Expands Equity with New Share Issuance
Neutral
May 1, 2025

Oxford Nanopore Technologies PLC announced the issuance of 5,007,671 ordinary shares following the exercise of options and remuneration schemes, which are now listed on the London Stock Exchange. This increases the company’s total voting rights to 960,454,923, providing a new denominator for shareholders to calculate their interests in accordance with FCA rules.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Executive/Board Changes
Oxford Nanopore Releases Shares to CEO Under LTIP
Neutral
Apr 30, 2025

Oxford Nanopore Technologies PLC announced the release of 42,953 ordinary shares under its Long-Term Incentive Plan (LTIP) to CEO Gordon Sanghera. This release, part of a performance-related award granted in 2021, required Sanghera to sell a portion of the shares to meet tax obligations, with the remaining shares retained. The transaction, conducted on the London Stock Exchange, highlights the company’s ongoing commitment to rewarding its leadership while maintaining transparency in its executive compensation practices.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Shareholder MeetingsFinancial DisclosuresRegulatory Filings and Compliance
Oxford Nanopore Technologies Publishes 2024 Annual Report and Announces 2025 AGM
Neutral
Apr 30, 2025

Oxford Nanopore Technologies plc has released its 2024 Annual Report and Accounts and announced its 2025 Annual General Meeting. The company encourages shareholders to participate in the AGM, which will be held on June 4, 2025, at their Oxford offices. This announcement is part of their compliance with regulatory requirements and provides shareholders with insights into the company’s financial status and governance.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Business Operations and StrategyRegulatory Filings and Compliance
Oxford Nanopore Technologies Sees Increase in Voting Rights by Major Shareholder
Neutral
Apr 24, 2025

Oxford Nanopore Technologies PLC has announced a change in the voting rights held by EIT Oxford Holdings, LLC, which has increased its stake to 13.0576% from a previous 12.1864%. This change signifies a notable shift in shareholder structure, potentially impacting the company’s governance and strategic decisions, as EIT Oxford Holdings, LLC, linked to Lawrence J. Ellison, now holds a significant portion of voting rights.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Executive/Board ChangesBusiness Operations and Strategy
Oxford Nanopore Technologies Announces LTIP and DBP Awards for Directors
Positive
Apr 14, 2025

Oxford Nanopore Technologies PLC announced the grant and vesting of awards under its Long Term Incentive Plan (LTIP) and Deferred Bonus Plan (DBP) for its directors. The awards, which are part of the company’s employee share plans, are designed to align the interests of management with shareholders and are contingent upon meeting specific performance conditions. This strategic move underscores the company’s commitment to incentivizing its leadership team, potentially enhancing its competitive positioning in the biotechnology sector.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Executive/Board ChangesBusiness Operations and StrategyRegulatory Filings and Compliance
Oxford Nanopore Awards Shares to CFO Under Incentive Plan
Neutral
Apr 14, 2025

Oxford Nanopore Technologies PLC announced a transaction involving its Share Incentive Plan (SIP) where Nick Keher, the company’s Chief Financial Officer, was awarded 129 Partnership Shares. These shares were purchased using his gross salary at a price of £1.16 per share. Additionally, the company issued 129 Matching Shares to the SIP Trustee to hold on behalf of Keher, reflecting the company’s commitment to employee investment and retention strategies. This move underscores the company’s adherence to UK Market Abuse Regulation and highlights its efforts to align managerial interests with shareholder value.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Business Operations and Strategy
Oxford Nanopore Sees Shift in Shareholder Voting Rights
Neutral
Apr 10, 2025

Oxford Nanopore Technologies PLC has announced a change in the voting rights held by EIT Oxford Holdings, LLC, which now holds 12.1864% of the company’s voting rights, up from 11.0673%. This increase in voting rights signifies a notable shift in shareholder influence, potentially impacting the company’s strategic decisions and stakeholder dynamics.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC shows strong revenue growth and strategic market positioning, supported by positive corporate events and a favorable earnings call. However, ongoing unprofitability, cash flow challenges, and a bearish technical outlook weigh down the score. The negative P/E ratio and lack of dividend yield also detract from its attractiveness.

To see Spark’s full report on GB:ONT stock, click here.

Product-Related AnnouncementsBusiness Operations and Strategy
Oxford Nanopore and Cepheid Collaborate on Sequencing Solutions
Positive
Apr 9, 2025

Oxford Nanopore Technologies and Cepheid have announced a strategic collaboration to create an automated sequencing workflow for infectious diseases. This partnership aims to simplify and accelerate sequencing processes, making them accessible to labs without prior expertise, and has potential applications in other areas like cancer and human genetics.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

Oxford Nanopore Technologies PLC’s overall stock score reflects strong revenue growth and strategic market positioning, countered by ongoing unprofitability and cash flow challenges. Technical indicators suggest a bearish trend, and the valuation remains unattractive due to a negative P/E ratio. Positive corporate events and earnings call sentiment somewhat bolster the outlook.

To see Spark’s full report on GB:ONT stock, click here.

Delistings and Listing Changes
Oxford Nanopore Technologies Updates Share Capital and Voting Rights
Neutral
Apr 2, 2025

Oxford Nanopore Technologies PLC announced the issuance of 69,402 ordinary shares following the exercise of options and remuneration schemes, with these shares admitted to the FCA’s Official List and trading on the London Stock Exchange. The company’s total issued share capital now consists of 955,447,252 ordinary shares, providing stakeholders with updated information on voting rights and shareholding calculations.

Regulatory Filings and Compliance
Oxford Nanopore Director Increases Stake with Share Purchase
Positive
Mar 26, 2025

Oxford Nanopore Technologies PLC announced that Kate Priestman, a Non-Executive Director, purchased 17,726 ordinary shares of the company at £1.120324 per share. This transaction, disclosed under the UK Market Abuse Regulation, indicates a potential vote of confidence in the company’s future prospects by its management, potentially impacting investor sentiment positively.

Business Operations and StrategyRegulatory Filings and Compliance
Oxford Nanopore Clarifies PDMR Notification and Announces Share Awards
Neutral
Mar 14, 2025

Oxford Nanopore Technologies PLC announced a correction to a previous PDMR Notification, clarifying that no corrections were needed. The company disclosed that Nick Keher, its Chief Financial Officer, was awarded 150 Partnership Shares and 150 Matching Shares under the Share Incentive Plan (SIP), with the transactions conducted on the London Stock Exchange. This announcement underscores the company’s commitment to transparency and regulatory compliance, potentially reinforcing stakeholder trust.

Business Operations and Strategy
Oxford Nanopore Technologies Announces Share Incentive Plan Transaction
Positive
Mar 13, 2025

Oxford Nanopore Technologies PLC announced a transaction involving the Share Incentive Plan (SIP) for Nick Keher, the company’s Chief Financial Officer. On March 12, 2025, 150 ordinary shares were purchased on behalf of Keher using his gross salary, with an equal number of matching shares granted under the SIP. This move highlights the company’s commitment to aligning managerial interests with shareholder value, potentially impacting the company’s market perception positively.

Regulatory Filings and Compliance
Oxford Nanopore Director Increases Stake with Share Purchase
Positive
Mar 12, 2025

Oxford Nanopore Technologies PLC announced that John O’Higgins, a Non-Executive Director, purchased 77,000 ordinary shares of the company at a price of £0.9717 per share. This transaction, disclosed under the UK Market Abuse Regulation, indicates a potential vote of confidence in the company’s prospects by a key member of its leadership team.

Regulatory Filings and Compliance
Oxford Nanopore Technologies Announces Change in Voting Rights
Neutral
Mar 6, 2025

Oxford Nanopore Technologies PLC has announced a change in the voting rights held by EIT Oxford Holdings, LLC. The company has disclosed that EIT Oxford Holdings, LLC now holds 11.0673% of the voting rights, up from a previous position of 10.947%. This change reflects an acquisition or disposal of voting rights, indicating a shift in stakeholder influence within the company.

Business Operations and Strategy
EIT Oxford Holdings Increases Stake in Oxford Nanopore Technologies
Neutral
Mar 5, 2025

Oxford Nanopore Technologies PLC has announced that EIT Oxford Holdings, LLC, a company associated with Lawrence J. Ellison, has increased its voting rights in the company to 10.947%. This acquisition of voting rights signifies a notable shift in shareholder dynamics and could potentially impact the company’s strategic decisions and market positioning.

Product-Related AnnouncementsBusiness Operations and StrategyFinancial Disclosures
Oxford Nanopore Technologies Reports Strong 2024 Results and Strategic Growth
Positive
Mar 4, 2025

Oxford Nanopore Technologies announced its annual results for 2024, highlighting a 23% growth in underlying constant currency revenue and a strong operational momentum into 2025. The company launched four new products, expanded strategic collaborations, and achieved significant contract wins, positioning itself for sustainable growth despite macroeconomic uncertainties. Financially, the company reported an improvement in EBITDA loss and maintained a robust cash position, supported by strategic investments.

Delistings and Listing ChangesRegulatory Filings and Compliance
Oxford Nanopore Technologies Issues New Shares and Updates Voting Rights
Neutral
Mar 3, 2025

Oxford Nanopore Technologies PLC announced the issuance of 40,416 ordinary shares following the exercise of options under its share option plans and remuneration schemes. These shares have been admitted to the Financial Conduct Authority’s Official List and are trading on the London Stock Exchange. The company’s total issued share capital now consists of 955,377,850 ordinary shares, which stakeholders can use to assess their shareholding interests under FCA rules.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.